These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [CLINICAL AND BIOCHEMICAL STUDIES IN MYOPATHIES. 3. RECESSIVE X-CHROMOSOMAL MUSCULAR DYSTROPHY WITH RELATIVELY BENIGN COURSE]. ROTTHAUWE HW; KOWALEWSKI S Klin Wochenschr; 1965 Feb; 43():158-63. PubMed ID: 14258512 [No Abstract] [Full Text] [Related]
24. Carrier detection in X-linked Duchenne type muscular dystrophy. A pluridimensional investigation. Radu H; Migea S; Török Z; Bordeianu L; Radu A J Neurol Sci; 1968; 6(2):289-300. PubMed ID: 4179111 [No Abstract] [Full Text] [Related]
25. Pseudohypertrophic muscular dystrophy. A report of two generations in a Thai family. Shearin RB; Mansuwan P Am J Dis Child; 1973 Apr; 125(4):580-2. PubMed ID: 4699896 [No Abstract] [Full Text] [Related]
26. [Changes in the enzyme activity of muscle tissue in progressive muscular dystrophy]. Badalian LO; Tamarkina ED; Bondarenko ES; Zakoshchikova LV Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(1):72-6. PubMed ID: 5425803 [No Abstract] [Full Text] [Related]
27. [Progressive musclar dystrophy in the experience of the Pediatric Clinic of Florence. Longitudinal study of 43 subjects]. Adami Lami Conti C; Calandi C; Nistri R; Aulisi A; Bucciolini MG; Vannelli G; Ragazzini F Minerva Pediatr; 1981 May; 33(9):385-412. PubMed ID: 7019663 [No Abstract] [Full Text] [Related]
29. [Clinico-morphologic characteristics of X-linked pseudohypertrophic myopathy]. Demidov PV; Kop'eva TN; Potomskaia IZ; Grinio LP; Kopylova EN Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(5):641-6. PubMed ID: 936862 [TBL] [Abstract][Full Text] [Related]
30. [Effect of drug administration on the child with progressive muscular dystrophy]. Nakahara T; Annaka S; Baba T; Kanno M Iryo; 1969 Oct; 23(10):1319-27. PubMed ID: 5364983 [No Abstract] [Full Text] [Related]
31. [CLINICAL AND BIOCHEMICAL STUDIES IN MYOPATHIES. I. SERUM ENZYMES IN PROGRESSIVE MUSCULAR DYSTROPHY (TYPE I, II, IIIA)]. ROTTHAUWE HW; KOWALEWSKI S Klin Wochenschr; 1965 Feb; 43():144-50. PubMed ID: 14258511 [No Abstract] [Full Text] [Related]
32. Distal muscular dystrophy with autosomal recessive inheritance. Scoppetta C; Vaccario ML; Casali C; Di Trapani G; Mennuni G Muscle Nerve; 1984; 7(6):478-81. PubMed ID: 6543900 [TBL] [Abstract][Full Text] [Related]
36. Calcium stimulated enzyme efflux from human skeletal muscle. Anand R; Emery AE Res Commun Chem Pathol Pharmacol; 1980 Jun; 28(3):541-50. PubMed ID: 7403666 [TBL] [Abstract][Full Text] [Related]
37. Inflammatory ocular myopathy in systemic sclerosis (scleroderma). A case report and review of the literature. Arnett FC; Michels RG Arch Intern Med; 1973 Nov; 132(5):740-3. PubMed ID: 4750227 [No Abstract] [Full Text] [Related]
38. [Significance of enzyme variations in polytraumatic patients]. Mörl FK; Heller W Langenbecks Arch Chir; 1968; 322():1111-3. PubMed ID: 5758695 [No Abstract] [Full Text] [Related]
39. [Enzyme patterns of healthy and pathologically changed human muscles]. Kleine TO Z Klin Chem Klin Biochem; 1967 Sep; 5(5):244-7. PubMed ID: 4248138 [No Abstract] [Full Text] [Related]
40. Clinical symptoms in a female carrier of Duchenne muscular dystrophy. Zatz M; Levisky RB; Levy JA; Valente BO; Gianotti M; Frota-Pessoa O J Genet Hum; 1973 Dec; 21(4):297-305. PubMed ID: 4792239 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]